- Home
- MUZE vs FENC Comparison
MUZE vs FENC Comparison
Compare MUZE & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$12.09
Company Overview
Basic Information| Metric | MUZE | FENC |
|---|---|---|
| Founded | 2025 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 271.6M | 230.8M |
| IPO Year | 2025 | 2010 |
Fundamental Metrics
Financial Performance| Metric | MUZE | FENC |
|---|---|---|
| Price | $9.99 | $12.09 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $14.50 |
| AVG Volume (30 Days) | 6.5K | ★ 167.2K |
| Earning Date | N/A | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.01 |
| Revenue | N/A | ★ $44,642,000.00 |
| Revenue This Year | N/A | $65.12 |
| Revenue Next Year | N/A | $41.08 |
| P/E Ratio | ★ N/A | $1,183.00 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.83 | $5.65 |
| 52 Week High | $9.99 | $13.25 |
Technical Indicators
Market Signals| Indicator | MUZE | FENC |
|---|---|---|
| Relative Strength Index (RSI) | 71.62 | 61.87 |
| Support Level | $9.93 | $7.40 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.01 | 0.75 |
| MACD | 0.00 | 0.22 |
| Stochastic Oscillator | 100.00 | 69.64 |
Price Performance
Historical Comparison MUZE
FENC
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.